parkinson's disease retatrutide clinical trial nct The NADPARK study: A randomized phase I of nicotinamide riboside supplementation in Current Therapies in Trials – retatrutide parkinson's disease trial Time-to-event
Pay in 4 interest-free payments of $6.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25























